CHI conference on microRNAs: dramatic expansion of research tools and discoveries

Expert Review of Molecular Diagnostics
Clark D Jeffries

Abstract

The Cambridge Health Institute's sixth annual conference on microRNAs integrated exceedingly diverse academic and commercial interests. Included were novel technologies for microRNA profiling and nucleic acid sequencing, drug delivery technologies using gene therapy, and promising diagnoses and treatments for various diseases, especially types of cancer. The conference format comprised 42 presentations, each 25 min in length. This article gives telegraphic descriptions of ten of the presentations, to illustrate the range of conference topics. At least two other mutually nonintersecting choices of ten could have been used with equal effect.

References

Nov 16, 2002·Proceedings of the National Academy of Sciences of the United States of America·George Adrian CalinCarlo M Croce
Dec 2, 2008·Nature Methods·Bernhard GentnerLuigi Naldini
Jun 16, 2009·Cell·Scott ValastyanRobert A Weinberg
Jul 18, 2009·Nature Reviews. Genetics·Brian D Brown, Luigi Naldini
Oct 31, 2009·Genes & Development·Scott ValastyanRobert A Weinberg
Nov 7, 2009·Nature Nanotechnology·Leyla SoleymaniShana O Kelley
Nov 26, 2009·The International Journal of Biochemistry & Cell Biology·Marina BagnoliDelia Mezzanzanica
Feb 18, 2010·Transfusion·Meganathan Kannan, Chintamani Atreya
Apr 13, 2010·Brain Research·Kai-Christian Sonntag
Jul 27, 2010·Transfusion Medicine Reviews·Sandhya KulkarniChintamani D Atreya

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.